Sara Kenkare-Mitra, President and Head of R&D at Alector, holds 318.85K shares in Alector (Ticker: ALEC), holds ― shares in Unicycive Therapeutics (Ticker: UNCY). Most recently, Sara Kenkare-Mitra Sold ― shares of Alector on Mar 05, 2024 for an estimated value of 70.37K.